# Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity

> **NCT02442375** · PHASE3 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 300 (actual)

## Conditions studied

- Head and Neck Neoplasms
- Carcinoma, Squamous Cell

## Interventions

- **RADIATION:** standard dose prescription
- **RADIATION:** FDG-PET guided gradient dose prescription

## Key facts

- **NCT ID:** NCT02442375
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2024-07-03
- **Final completion:** 2024-07-03
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02442375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02442375, "Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02442375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*